Literature DB >> 22546912

[Biomarkers in rheumatology. Biomarkers and imaging for the diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the ArthroMark network funded by the Federal Ministry of Education and Research].

T Häupl1, H Appel, M Backhaus, H Burkhardt, M Grünke, A Grützkau, B Hoppe, J Listing, B Ostendorf, M Rudwaleit, J Sieper, A Skapenko, K Skriner, T Sörensen, B Stuhlmüller, A Zink, H Schulze-Koops, G-R Burmester.   

Abstract

The introduction of biologics has continuously increased the demand for biomarkers for early diagnosis and therapeutic stratification. ArthroMark, a research network funded by the Federal Ministry of Education and Research, aims to establish such biomarkers for rheumatoid arthritis and spondyloarthritides. Biobanks and previous work on genotyping, gene expression and autoreactivity profiling build the basis. Bioinformatic networks will help to harmonize the investigations and a clinical study with modern imaging techniques to characterize the functional relevance of the new biomarkers as effectively as possible. To validate the markers for diagnostic application the network aims to expand gradually.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22546912     DOI: 10.1007/s00393-011-0781-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  9 in total

1.  Prothrombin 20210G>A genotype and C-reactive protein level.

Authors:  Berthold Hoppe; Gerd-Rüdiger Burmester; Thomas Häupl
Journal:  Blood       Date:  2011-10-20       Impact factor: 22.113

2.  Fibrinogen and factor XIII A-subunit genotypes interactively influence C-reactive protein levels during inflammation.

Authors:  Berthold Hoppe; Thomas Häupl; Alla Skapenko; Sabine Ziemer; Rudolf Tauber; Abdulgabar Salama; Hendrik Schulze-Koops; Gerd-Rüdiger Burmester; Thomas Dörner
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

3.  Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis.

Authors:  Iryna Prots; Alla Skapenko; Jörg Wendler; Stefan Mattyasovszky; Clarisse L Yoné; Bernd Spriewald; Harald Burkhardt; Rolf Rau; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
Journal:  Arthritis Rheum       Date:  2006-05

4.  Crystal structure of an arthritogenic anticollagen immune complex.

Authors:  Doreen Dobritzsch; Ingrid Lindh; Hüseyin Uysal; Kutty S Nandakumar; Harald Burkhardt; Gunter Schneider; Rikard Holmdahl
Journal:  Arthritis Rheum       Date:  2011-12

Review 5.  Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics.

Authors:  Heiner Appel; Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

6.  Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project.

Authors:  M Backhaus; S Ohrndorf; H Kellner; J Strunk; T M Backhaus; W Hartung; H Sattler; K Albrecht; J Kaufmann; K Becker; H Sörensen; L Meier; G R Burmester; W A Schmidt
Journal:  Arthritis Rheum       Date:  2009-09-15

7.  Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.

Authors:  B Hoppe; T Häupl; K Egerer; R Gruber; H Kiesewetter; A Salama; G R Burmester; T Dörner
Journal:  Ann Rheum Dis       Date:  2008-07-16       Impact factor: 19.103

8.  CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis.

Authors:  B Stuhlmüller; T Häupl; M M Hernandez; A Grützkau; R-J Kuban; N Tandon; J W Voss; J Salfeld; R W Kinne; G R Burmester
Journal:  Clin Pharmacol Ther       Date:  2009-12-23       Impact factor: 6.875

9.  Inflammation assessment in patients with arthritis using a novel in vivo fluorescence optical imaging technology.

Authors:  Stephanie G Werner; Hans-Eckhard Langer; Sarah Ohrndorf; Malte Bahner; Peter Schott; Carsten Schwenke; Michael Schirner; Hans Bastian; Gudrun Lind-Albrecht; Bernward Kurtz; Gerd R Burmester; Marina Backhaus
Journal:  Ann Rheum Dis       Date:  2012-04       Impact factor: 19.103

  9 in total
  1 in total

Review 1.  [Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis: Where do we stand?].

Authors:  B Stuhlmüller; K Skriner; T Häupl
Journal:  Z Rheumatol       Date:  2015-11       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.